lobbying_activities: 2467109

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2467109	e337b789-019f-49f1-bed6-f1949b818dc8	Q2	MEHLMAN CONSULTING, INC.	284950	BLUE SHIELD OF CALIFORNIA	2020	second_quarter	INS	Issues related to health insurance and prescription drug pricing. S.1895 - Lower Health Care Costs Act S.1531 - Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 H.R. 3630 - No Surprises Act H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act COBRA Subsidies	Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2020-07-15T18:13:24.603000-04:00